| Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and ... - AUTO-MOBI.info |
|
|
AUTO-MOBI.infoLIVALO has not been studied in patients with severe renal impairment (glomerular filtration rate < 30 mL/min/1.73 m2) not on hemodialysis. ... read more |